Andrea Čumová, M.Sc.

MiR-140 leads to MRE11 downregulation and ameliorates oxaliplatin treatment and therapy response in colorectal cancer patients.

Department of Molecular Biology of Cancer Horák J.Dolníková A.Cumaogullari O.Čumová A.Navvabi N.Vodičková L.Levy M.Schneiderová M.Liška V.Andera L.Vodička P.Opattová A. 2022 Frontiers in Oncology. 12:959407.

Telomere length in peripheral blood lymphocytes related to genetic variation in telomerase, prognosis and clinicopathological features in breast cancer patients.

Department of Molecular Biology of Cancer Department of Toxicology and Molecular Epidemiology Kroupa M.Rachakonda S.Vymetálková V.Tomášová K.Liška V.Vodenková S.Čumová A.Rössnerová A.Vodičková L.Hemminki K.Souček P.Kumar R.Vodička P. 2020 Mutagenesis. 35(6):491-497.

Genetic variations in 3'UTRs of SMUG1 and NEIL2 genes modulate breast cancer risk, survival and therapy response.

Department of Molecular Biology of Cancer Čumová A.Vymetálková V.Opattová A.Boušková V.Pardini B.Kopečkov K.Kozevnikovová R.Licková K.Ambrus M.Vodičková L.Naccarati A.Souček P.Vodička P. 2021 Mutagenesis. 36(4): 269-279.